spacer
home > pmps > spring 2007 > keeping your cool over short-distance shipping
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Keeping Your Cool Over Short-Distance Shipping

Specifying a suitable controlled packaging solution when transporting temperature-sensitive pharmaceuticals over short distances is becoming increasingly important, explains Geraint Thomas of Laminar Medica

Every day, packages containing temperature-sensitive pharmaceuticals are dispatched from one location and delivered to another nearby. Whether travelling from a pharmacy to the local doctor’s surgery, or a storage facility to a beauty treatment centre, the sensitivity of these products is commonly overlooked due to the short distances and durations involved.

While pharmaceuticals shipped internationally across the globe are protected by sophisticated and effective temperature-controlled packaging systems, these types of solutions are typically not considered to be cost effective when the products are being taken just a few miles. The result is that short duration packaging solutions are either inadequate or, conversely, over-specified.

PADDED ENVELOPES

In order to cut costs, many organisations regularly use standard and inexpensive padded envelopes designed to offer physical protection only, with conventional ice packs inside in an attempt to control the temperature of the drugs being shipped. However, this type of over-simplified solution presents a number of significant problems to users.

Firstly, padded envelopes that are not designed to offer a controlled temperature environment for their contents offer no known levels of protection; it is impossible to reliably estimate how long a product will remain at its desired temperature and what temperature range the package will be capable of maintaining. Using padded envelopes therefore relies on guesswork, putting the integrity of the pharmaceuticals being sent at risk.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Geraint Thomas graduated from Brunel University in 1996 with a BSc in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist, with responsibility for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
spacer
Geraint Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement